Medtech venture investing trends: Here ’ s what you need to know
Ask any early-stage medtech or digital health entrepreneur, and they’ll tell you how tough it is. There’s tremendous competition for venture investing, coupled with a pullback by previously traditional investors in this space. Bill Evans [Image from Nick Morrison on Unsplash]While venture investment in medtech and digital health has recovered since the financial crisis of a decade ago — setting a record in 2017 — this doesn’t reflect what it’s like for entrepreneurs raising money at that critical transition from seed money to Series A. The bar for new investments is considerably raised, ...
Source: Mass Device - June 21, 2018 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News Funding Roundup mHealth (Mobile Health) billevans Medtech Innovator Silicon Valley Bank startups venture capital Source Type: news

Mercator MedSystems Receives $11M in Series D Equity Financing Led by Shenzhen Salubris Pharmaceuticals Co.
Capital will fuel continued research and clinical development of micro-infusion platform EMERYVILLE, Calif., June 21, 2018 -- (Healthcare Sales & Marketing Network) -- Mercator MedSystems, Inc., today announced it has received $11 million in Series D e... Devices, Interventional, Venture Capital Mercator MedSystems, Shenzhen Salubris Pharmaceuticals, Bullfrog, Micro-Infusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2018 Category: Pharmaceuticals Source Type: news

AdoRx Therapeutics Announces Initial Funding of $10 Million for the Discovery of New Cancer Therapeutics
EDINBURGH, Scotland, June 21, 2018 -- (Healthcare Sales & Marketing Network) -- AdoRx Therapeutics, a UK based drug discovery company focused on the identification of new cancer therapeutics, today announced that it has closed an initial $10 million inves... Biopharmaceuticals, Oncology, Venture Capital AdoRx Therapeutics, adenosine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2018 Category: Pharmaceuticals Source Type: news

Alpha Biopharma Announces Series A Financing
SHANGHAI, June 19, 2018 -- (Healthcare Sales & Marketing Network) -- Alpha Biopharma Inc. ("AlphaBio") today announced the first $37M closing of its $65M Series A financing led by Qiming Venture Partners, one of the most prominent venture capita... Biopharmaceuticals, Oncology, Venture Capital, Personnel Alpha Biopharma, NSCLC, tyrosine kinase inhibitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2018 Category: Pharmaceuticals Source Type: news

Peter Thiel fund invests in Boston-based 'organs-on-chips ’ startup
Emulate Inc., a Boston-based startup that is developing “organs-on-chips” for testing experimental drugs, has a prominent new investor: Founders Fund, the San Francisco-based venture capital firm co-founded by billionaire Peter Thiel. Emulate announced Tuesday that it has secured a $36 million Series C round led by Founders Fund. The VC firm was an early investor in Facebook; its portfolio also includes Airbnb, Elon Musk’s rocket manufacturer SpaceX, and Thiel’s data-mining company Palantir. Emulate… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 19, 2018 Category: American Health Authors: Max Stendahl Source Type: news

StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform
Financing Will Enable Stride to Move Multiple Programs Towards the Clinic DURHAM, N.C., June 13, 2018 -- (Healthcare Sales & Marketing Network) -- StrideBio, Inc, a US-based company developing novel AAV vectors for in vivo gene therapies announced toda... Biopharmaceuticals, Venture Capital, Personnel StrideBio, gene therapy, gene editing (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2018 Category: Pharmaceuticals Source Type: news

Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo
Bill & Melinda Gates Foundation, Li Ka Shing Foundation Lead New Funding Round to Expand Groundbreaking Progress in Restoring Infant Gut Microbiome and to Lay a Global Foundation for Long-Term Nutritional and Immune Health DAVIS, Calif., June 13, 2018 -... Biopharmaceuticals, Gastroenterology, Venture Capital Evolve BioSystems, microbiome, gut microbiome, Evivo (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2018 Category: Pharmaceuticals Source Type: news

Elbit Systems' Surgeon-Centered Visualization Spin-Off, Beyeonics, Raises $11.5 Million
HAIFA, Israel, June 13, 2018 -- (Healthcare Sales & Marketing Network) -- Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems") announced today that it's subsidiary, Beyeonics Surgical Ltd. ("Beyeonics"), concluded a first r... Devices, Surgery, Venture Capital Elbit Systems, Beyeonics Surgical, Clarity Bionic Visualization (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2018 Category: Pharmaceuticals Source Type: news

Vergent Bioscience Raises $8.7 Million in Series A Financing Led by Spring Mountain Capital
MINNEAPOLIS, June 12, 2018 -- (Healthcare Sales & Marketing Network) -- Vergent Bioscience, a cancer-focused biotechnology company, announced today that it raised $8.7 million in a Series A financing round led by Spring Mountain Capital to fund its precli... Diagnostics, Oncology, Venture Capital Spring Mountain Capital, Vergent Bioscience, fluorescent probe (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 12, 2018 Category: Pharmaceuticals Source Type: news

Propeller Health Raises Strategic Investment from McKesson Ventures
MADISON, Wis., June 11, 2018 -- (Healthcare Sales & Marketing Network) -- Propeller Health, a leading digital therapeutics company, announced a strategic investment of an undisclosed amount from McKesson Ventures, adding to the $20M funding round announce... Devices, Venture Capital Propeller Health, digital therapeutics, digital medicines, Asthma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 11, 2018 Category: Pharmaceuticals Source Type: news

Gaithersburg biopharma company Sirnaomics raises $25M
Key story highlights: Gaithersburg-based Sirnaomics Inc. has raised $25 million in Series C1 funding. The company, which develops anti-fibrosis and anti-cancer RNAi therapeutics, will use the capital to push forward its clinical programs, expand development of new drug candidates and grow its management team. It last r aised $10 million in a Series B round in 2016, which followed previous venture capital investment and grant funding totaling $25 million at that time. Gaithersburg's Sirnaomics… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 7, 2018 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news

BIOMODEX Raises an Additional $15M in Series A Funding
Latest investment from Idinvest Partners and InnovAllianz to support technological development and enable the opening a manufacturing facility in Massachusetts Boston, June 07, 2018 -- (Healthcare Sales & Marketing Network) -- BIOMODEX, a medical devic... Devices, Venture Capital BIOMODEX, 3D Printing, synthetic organ (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 7, 2018 Category: Pharmaceuticals Source Type: news

SutroVax Announces $85M Series C Financing led by TPG Growth
Provides growth capital to advance pneumococcal vaccine to clinic and beyond Preeminent executive vaccinologist, Moncef Slaoui, appointed Board Chairman Strategic alignment established with Lonza Pharma & Biotech to create end-to-end supply chain ... Biopharmaceuticals, Venture Capital, Personnel SutroVax, pneumococcal vaccine, vaccine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 7, 2018 Category: Pharmaceuticals Source Type: news

Oncologie Launches with 16.5M USD Seed Funding Led by Pivotal bioVenture Partners China
BOSTON and SHANGHAI, June 7, 2018 -- (Healthcare Sales & Marketing Network) -- Oncologie, an innovative biopharmaceutical company, announced today that it is launching operations in both Boston and Shanghai with $16.5M seed financing led by Pivotal bioVen... Biopharmaceuticals, Oncology, Venture Capital Oncologie, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 7, 2018 Category: Pharmaceuticals Source Type: news

DRIVe (Division of Research, Innovation, and Ventures)
U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. 06/2018 This program, established by the Biomedical Advanced Research and Development Authority (BARDA), part of the Assistant Secretary for Preparedness and Response (ASPR), takes a new approach to tackle the biggest national health security threats by developing innovative technologies and practices for transformative solutions. It brings together the best ideas from the medical and scientific communities, together with government and venture capital investment, to drive innovation that will strengthen the natio...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - June 6, 2018 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Pfizer to pump $600 million in additional funding into biotech startups
Pfizer Inc. is looking to deploy millions into biotech startups. The New York-based pharmaceutical giant (NYSE: PFE) unveiled plans Wednesday to invest $600 million into emerging growth companies through its venture capital arm, Pfizer Ventures. The move likely will include a hiring spree, as Pfizer looks to expand its team across several areas of venture capi tal investing, including business development, drug discovery and clinical development. Pfizer Vice President Barbara Dalton praised the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 6, 2018 Category: Pharmaceuticals Authors: Anthony Noto Source Type: news

Pfizer to expand venture investing with $600 million commitment to Pfizer Ventures
Pfizer Inc. (NYSE:PFE) today announced it plans to invest $600 million in biotechnology and other emerging growth companies through Pfizer Ventures, the company’s venture investment vehicle. In addition to increased funding, Pfizer will extend its leadership as a venture capital investor with an expanded team that leverages expertise across venture capital investing, business development, drug discovery and clinical development. (Source: World Pharma News)
Source: World Pharma News - June 6, 2018 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

Philips to acquire EPD solutions in $293m upfront deal
Royal Philips (NYSE:PHG) said today it inked a deal to acquire image-guided cardiac arrhythmia treatment dev EPD Solutions for $293 million (EU €250 million) upfront with a possible additional $246.2 million (EU €210 million) upon completion of the deal based on certain milestones. EPD Solutions produces cardiac imaging and navigation systems designed to aid electrophysiologists in navigating the heart through a detailed 3D image of the cardiac anatomy, Amsterdam-based Philips said. The system is also designed to identify the location and orientation of catheters during the diagnostic and therapeutic pr...
Source: Mass Device - June 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Mergers & Acquisitions royalphilips Source Type: news

Portland pet care specialists land a $50M funding round
A company that specializes in home delivery of pet medications has landed $50 million from a big-name investor. Portland-based Vetsource, which had also raised $12 million in 2015, reported the Series D round Tuesday morning. Bain Capital Ventures, the venture capital affiliate of Bain Capital, led the round. It's one of the largest funding rounds this year and comes on the heels of a reported $100 million -plus round by the legal software company Exterro. Vetsource said it will use the money… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 5, 2018 Category: American Health Authors: Andy Giegerich Source Type: news

Biotech has a problem: Too many startups, too little experience
Biotech ’s golden age is full of gray. As new technologies accelerate the pace of biotech discoveries, the first generation of life sciences legends isn’t ceding to a new wave of entrepreneurs. Instead, young founders and old-school company creators are reaching across the generation gap. That coopera tion could have a profound impact on how fresh ideas are spun into companies — and who pulls down ballooning venture capital rounds. At the heart of it all is a fear that the rate of scientific… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 5, 2018 Category: American Health Authors: Ron Leuty Source Type: news

Philips signs deal to buy EPD Solutions
In a deal aimed at broadening its image-guided therapy offerings, Royal Philips...Read more on AuntMinnie.comRelated Reading: Philips to implement Dana-Farber's cancer support tool Philips, AHA to launch $30M venture capital fund Report: Philips to cut more jobs in Cleveland Long-term deals and AI drive Q1 sales growth at Philips Philips launches new 3T MRI scanner at ECR 2018 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 5, 2018 Category: Radiology Source Type: news

Philips wins FDA clearance for Ingenia Elition MRI scanner
Philips Healthcare has garnered U.S. Food and Drug Administration (FDA) 510(k)...Read more on AuntMinnie.comRelated Reading: Philips to implement Dana-Farber's cancer support tool Philips, AHA to launch $30M venture capital fund Report: Philips to cut more jobs in Cleveland Long-term deals and AI drive Q1 sales growth at Philips Philips launches new 3T MRI scanner at ECR 2018 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 5, 2018 Category: Radiology Source Type: news

Cytrellis Biosystems Completes $28.5 Million Series B Financing
Supports company's clinical, product development and regulatory efforts Michael Peterson, CTO Merz Device Innovation Center, joins Board of Directors WOBURN, Mass., June 5, 2018 -- (Healthcare Sales & Marketing Network) -- Cytrellis Biosystems, Inc.... Devices, Dermatology, Venture Capital, Personnel Cytrellis Biosystems (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 5, 2018 Category: Pharmaceuticals Source Type: news

Musculoskeletal concierge service Risalto Health rakes in $1.5M in seed funding
New York-based musculoskeletal digital health platform Risalto Health has just landed $1.5 million in seed funding from Health Catalyst Capital Management, a venture capital firm focused on health companies.   The platform works as a concierge service using machine learning and AI to identify muscular and skeletal health providers in an area, such as physical therapists, doctors, and surgeons. Risalto then links patients and employers to those providers based on needs.  (Source: mobihealthnews)
Source: mobihealthnews - June 5, 2018 Category: Information Technology Source Type: news

Former Publix CEO backs South Florida startup in $4.5M funding round
Bridge Connector, a Palm Beach Gardens-based startup, has secured $4.5 million in its first major funding round since its May 2017 founding. Tampa-based venture capital firm Axioma Partners LLC led the seed capital raise. Other backers included Howard Jenkins, the billionaire former chairman and CEO of Publix Super Markets. With the new capital, Bridge Connector plans to hire developers and bolster its support, sales and management te ams. The startup currently has 25 full-time employees, and expects… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 5, 2018 Category: Biotechnology Authors: Emon Reiser Source Type: news

BD lifts Bard vet DeFord to CTO | Personnel Moves – June 4, 2018
Becton Dickinson (NYSE:BDX) said last Friday it is lifting former C.R. Bard science, technology and clinical affairs senior VP John DeFord to the role of chief technology officer and exec VP. Since acquiring Bard in a $24 billion deal that closed last December, DeFord has served as BD interventional segment R&D SVP, the Franklin Lakes, N.J.-based company said. DeFord originally joined Bard as science & tech VP in 2004, and had previously served life sciences managing director for venture capital fund Early Stage Partners and as prez & CEO of Cook Inc, which is now known as Cook Medical. He also curren...
Source: Mass Device - June 4, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News bectondickinson Cook Medical crbard ectosense integer meddux Merit Medical Systems Inc. Nuvasive Optovue polarityte RenalGuard Solutions Teleflex Vital Connect Source Type: news

These 7 companies have received the most funding for anti-aging research
The promise of companies that can somehow delay the inevitable — aging — is fueling increased investment in biotech businesses that directly target human longevity or individual age-related diseases. In 2017, $559.4 million in venture capital was invested in U.S. anti-aging companies —158 percent more than five years ago, according to data from Pitchbook, which tracks VC funding. Many of these anti-aging companies and investors are located in the Bay Area. Here’s a look at the most funded… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 31, 2018 Category: American Health Authors: Julia Cooper Source Type: news

Biotech has an age problem: Too many startups, too little experience
Biotech ’s golden age is full of gray. As new technologies accelerate the pace of biotech discoveries, the first generation of life sciences legends isn’t ceding to a new wave of entrepreneurs. Instead, young founders and old-school company creators are reaching across the generation gap. That coopera tion could have a profound impact on how fresh ideas are spun into companies — and who pulls down ballooning venture capital rounds — in the Bay Area. At the heart of it all is a fear that… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 31, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

Philips to implement Dana-Farber's cancer support tool
Royal Philips said it will integrate Dana-Farber Cancer Institute's clinical...Read more on AuntMinnie.comRelated Reading: Philips, AHA to launch $30M venture capital fund Report: Philips to cut more jobs in Cleveland Long-term deals and AI drive Q1 sales growth at Philips Philips, Digital China Health partner on teleradiology Philips signs with IIT on teleultrasound (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 31, 2018 Category: Radiology Source Type: news

Why Lewis & Clark Ventures thinks transportation can transform health care
The venture capital firm has invested in a medical ride-sharing startup. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 31, 2018 Category: Pharmaceuticals Authors: Steph Kukuljan Source Type: news

Propeller Health Raises $20 Million, Accelerating Development of Digital Medicines for Respiratory Health and Other Diseases
Financing led by Aptar Pharma, with participation from existing investors Safeguard Scientifics, Social Capital, Hikma, 3M Ventures and SR One MADISON, Wis., May 30, 2018 -- (Healthcare Sales & Marketing Network) -- Propeller Health, a leading digital ... Devices, Venture Capital Propeller Health, digital therapeutics, digital medicines (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news

Neurent Medical sniffs out $11m for rhinitis device
Neurent Medical reportedly sniffed out a funding round of nearly $12 million for the minimally invasive rhinitis treatment it’s developing. The €9.3 million round for Oranmore, Ireland-based Neurent was led by Irish venture capital shop Fountain Healthcare Partners and included participation from Atlantic Bridge, Ireland’s Western Development Commission, Enterprise Ireland and a syndicate of U.S. and Irish medical device veterans, the Irish Times reported. According to its website, the single-use Neurent device uses radiofrequency energy to “interrupt the autonomic function within the ...
Source: Mass Device - May 29, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Otolaryngology Ear, Nose & Throat Wall Street Beat Neurent Medical Source Type: news

Lion TCR receives US$ 20 million to fund its personalized T cell therapy clinical trials against Liver cancer
SINGAPORE, May 28, 2018 -- (Healthcare Sales & Marketing Network) -- Lion TCR Pte Ltd, a clinical stage biotech pioneering T cell therapy against viral- related cancer, announced today they have raised US$ 20 million in its Series A financing round. The m... Biopharmaceuticals, Oncology, Venture Capital Lion TCR, LioCyx, T-cell, Hepatocellular carcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 28, 2018 Category: Pharmaceuticals Source Type: news

Armed with $50 million, can S.F. home care startup fix the pain of finding caregivers for the elderly?
Honor was one in a crop of home care startups professing to “disrupt” the existing home care market. It was boosted by hundreds of millions in venture capital funding. Now, it's revamping its business model. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 22, 2018 Category: American Health Authors: Kevin Truong Source Type: news

Heart Tx Investigation; Venture Capital; Stent Retrievers; CRT Survival
(MedPage Today) -- Recent developments of interest in cardiovascular medicine (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - May 21, 2018 Category: Urology & Nephrology Source Type: news

Philips, AHA, UPMC launch $30m heart-focused venture fund
Royal Philips (NYSE:PHG) said late last week it is joining with the American Heart Association and UPMC to launch a $30 million heart-focused collaborative venture capital fund. The newly formed Cardeation Capital fund will support innovation in products for treating heart disease and stroke care. The fund will be managed by Aphelion Capital, with each major player contributing $10 million, Amsterdam-based Philips said. Cardeation Capital will look to invest in companies trying to treat cardiovascular diseases and stroke and their risk factors, including diabetes, according to Philips. “At Philips our goal is to...
Source: Mass Device - May 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Wall Street Beat American Heart Assn. royalphilips UPMC Source Type: news

4 risks digital health companies need to face head-on
Digital health care companies are leading the revolution in consumer-centric healthcare, but the promise of breakthrough innovation and better patient outcomes won ’t be fully realized without a systematic approach to risk identification and management. Made possible by low-cost technology, abundant venture capital and the Internet of Things (IoT), digital healthcare companies are creating new business models and service delivery options. But in reshaping t he industry, digital health care companies… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 18, 2018 Category: Pharmaceuticals Authors: Brett Buchanan Source Type: news

4 risks digital health companies need to face head-on
Digital health care companies are leading the revolution in consumer-centric healthcare, but the promise of breakthrough innovation and better patient outcomes won ’t be fully realized without a systematic approach to risk identification and management. Made possible by low-cost technology, abundant venture capital and the Internet of Things (IoT), digital healthcare companies are creating new business models and service delivery options. But in reshaping t he industry, digital health care companies… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Brett Buchanan Source Type: news

American Heart Association Venture Capital Fund Sparks Criticism
The American Heart Association announcement of a $30 million venture capital fund sparks criticism on Twitter and from the Cleveland Clinic's Steve Nissen. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 17, 2018 Category: Pharmaceuticals Authors: Larry Husten, Contributor Tags: NYSE:PHG Source Type: news

Philips, AHA to launch $30M venture capital fund
Royal Philips has launched a $30 million venture capital fund to support...Read more on AuntMinnie.comRelated Reading: Report: Philips to cut more jobs in Cleveland Long-term deals and AI drive Q1 sales growth at Philips Philips to collaborate with Sun Nuclear Philips, Digital China Health partner on teleradiology Philips issues security advisory for PACS software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 17, 2018 Category: Radiology Source Type: news

UPMC, Philips, American Heart Association join forces for $30M venture capital fund
Cardeation Capital represents a new initiative in the AHA's efforts to foster even more innovation on the technical side of cardiovascular care, AHA CEO Nancy Brown said. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 17, 2018 Category: Health Management Authors: Paul J. Gough Source Type: news

UPMC, Philips, American Heart Association join forces for $30M venture capital fund
Cardeation Capital represents a new initiative in the AHA's efforts to foster even more innovation on the technical side of cardiovascular care, AHA CEO Nancy Brown said. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: Paul J. Gough Source Type: news

FogPharma Secures $66 Million Series B Financing
Company is pioneering a powerful new class of medicines - cell-penetrating miniproteins - with an on-demand drug discovery platform for the treatment of serious diseases driven by intractable targets BOSTON, May 16, 2018 -- (Healthcare Sales & Marketing... Biopharmaceuticals, Venture Capital, Personnel FogPharma, miniprotein (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news

EIP Pharma Secures $20.5 Million in Series B Financing
Proceeds to Support Continued Development of Neflamapimod for Alzheimer's Disease CAMBRIDGE, Mass., May 16, 2018 -- (Healthcare Sales & Marketing Network) -- EIP Pharma, a therapeutics company focused on CNS diseases, today announced the successful com... Biopharmaceuticals, Neurology, Venture Capital EIP Pharma, neflamapimod, p38 alpha, Alzheimer's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news

Exclusive: These Bay Area health tech startups pulled in the most funding last year
In many ways 2017 was a banner year for the health tech industry, with investment in the sector hitting an all-time-high. Since 2014, when health investment doubled to $4.4 billion, both deal flow and investment dollars have remained strong and continued a largely upward climb. For 2017, venture capital funding approached $6 billion, and the number of $100 million-plus funding deals also broke records, according to d igital health research and investment firm Rock Health. Among Bay Area health tech… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 15, 2018 Category: Pharmaceuticals Authors: Kevin Truong Source Type: news

Exclusive: These Bay Area health tech startups pulled in the most funding last year
In many ways 2017 was a banner year for the health tech industry, with investment in the sector hitting an all-time-high. Since 2014, when health tech investment doubled, both deal flow and investment dollars have remained strong and continued a largely upward climb. For 2017, venture capital funding across health tech reached $11.6 billion, and the number of $100 million-plus funding deals also broke records, accord ing to research from Startup Health. Among Bay Area health tech companies in 2017,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 15, 2018 Category: Biotechnology Authors: Kevin Truong Source Type: news

This local health IT startup just raised $2M in seed funding from some big names
Insightin Health, a Gaithersburg data startup that connects health insurers with consumers, has raised $2 million in seed financing. New York-based venture capital firm Health Catalyst Capital Management led the round, announced Tuesday, with participation from several local investors including Revolution’s Rise of the Rest Seed Fund, Maryland’s Technology Development Corp., SaaS Ventures, TCP Ventures and an angel group le d by Blu Venture Investors Founding Principal Paul Silber. The company,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 15, 2018 Category: American Health Authors: Sara Gilgore Source Type: news

Madison's Venture Investors starts $100M fund for health startups
Venture Investors, the largest venture capital fund in Wisconsin, is launching a $100 million fund dedicated to heath care startups, according to documents filed with the Securities and Exchange Commission. The Madison-based fund wouldn't elaborate on details of the fund when contacted by the Milwaukee Business Journal, citing regulatory protocol. Venture Investors currently manages more than $200 million in assets and invests in early stage health care startups involved in therapeutics, diagnostics ,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 15, 2018 Category: American Health Authors: Nick Williams Source Type: news

BrainQ Technologies Raises $8.8 Million to Treat Neurodisorders With Artificial Intelligence
Financing included Norma Investments, OurCrowd.com, and Qure Ventures JERUSALEM, May 15, 2018 -- (Healthcare Sales & Marketing Network) -- BrainQ, developing Artificial Intelligence (AI) powered technologies to treat neurodisorders in innovative ways, ... Devices, Neurology, Venture Capital BrainQ Technologies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2018 Category: Pharmaceuticals Source Type: news